Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Merck Provides Update on KEYTRUDA sBLA for KEYNOTE-042 Trial

americanpharmaceuticalreviewDecember 29, 2018

Tag: Merck , KEYTRUDA sBLA , KEYNOTE-042 Trial , NSCLC

PharmaSources Customer Service